Healthcare - Medical - Diagnostics & Research - NYSE - US
$ 187.74
-4.65 %
$ 9.6 B
Market Cap
23.44
P/E
Price Target
Average
26.06%
Revenue Forecast
Estimate
4.46%
EBIT
Estimate
7.87%
Net Income
Estimate
12.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Charles River Laboratories International, Inc.
Wall Street analysts predict an average 1-year price target for CRL of $237 , with forecasts ranging from a low of $151 to a high of $300 .
CRL Lowest Price Target
Wall Street Target
151 USD
-19.57%
CRL Average Price Target
Wall Street Target
237 USD
26.06%
CRL Highest Price Target
Wall Street Target
300 USD
59.80%
REVENUE FORECAST
Revenue Forecast Chart CRL
EBIT FORECAST
EBIT Forecast Chart CRL
NET INCOME FORECAST
Net Income Chart CRL